Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Griseofulvin 400mg/5ml oral suspension
0502050B0AABCBC
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 40mg/5ml oral suspension
0502050B0AABDBD
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 440mg/5ml oral suspension
0502050B0AACXCX
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 450mg/5ml oral suspension
0502050B0AAAMAM
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 500mg/5ml oral suspension
0502050B0AAAKAK
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 50mg/5ml oral suspension
0502050B0AAAIAI
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 55mg/5ml oral suspension
0502050B0AACACA
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 560mg/5ml oral suspension
0502050B0AACSCS
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 60mg/5ml oral suspension
0502050B0AACGCG
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 62.5mg/5ml oral suspension
0502050B0AABMBM
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 625mg/5ml oral suspension
0502050B0AAAHAH
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 65mg/5ml oral suspension
0502050B0AACCCC
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 700mg/5ml oral suspension
0502050B0AABYBY
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 70mg/5ml oral suspension
0502050B0AABXBX
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 75mg/5ml oral suspension
0502050B0AABVBV
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 80mg/5ml oral suspension
0502050B0AABIBI
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 85mg/5ml oral suspension
0502050B0AACECE
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 90mg/5ml oral suspension
0502050B0AAAYAY
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Grisol 1% spray
1310020Q0BBABAB
|
Grisol | Griseofulvin | Skin | No data available |
|
Grisol AF 1% spray
1310020Q0BBAAAB
|
Grisol | Griseofulvin | Skin | No data available |
|
Grisovin 125mg tablets
0502050B0BCAAAB
|
Grisovin | Griseofulvin | Infections | No data available |
|
Grisovin 500mg tablets
0502050B0BCABAC
|
Grisovin | Griseofulvin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.